US 7825092
Dendroaspis natriuretic peptide for treatment of cancer
granted A61KA61K38/1703A61K38/2242
Quick answer
US patent 7825092 (Dendroaspis natriuretic peptide for treatment of cancer) held by United States Department of Veteran Affairs expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Department of Veteran Affairs
- Grant date
- Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/1703, A61K38/2242, A61P, A61P35/00